Literature DB >> 17890748

Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.

Nathalie Terrier1, Isabelle Jaussent, Anne-Marie Dupuy, Marion Morena, Cécile Delcourt, Lotfi Chalabi, Catherine Rouanet, Bernard Canaud, Jean-Paul Cristol.   

Abstract

BACKGROUND: Malnutrition and inflammation are recognized as important predictors of poor clinical outcome in haemodialysis (HD). This study was designed to estimate the relative contribution of known biological markers of inflammation, malnutrition and muscle mass in the prognosis of HD patients.
METHODS: A total of 187 HD patients (100 women, 87 men, median age 66.7 years [22.3-93.5]) were followed-up yearly for 5 years. At baseline, pre-dialysis values of C-reactive protein (CRP), albumin, transthyretin, total HDL- and LDL-cholesterol and triacylglycerol were determined. Estimation of creatinine index (CI) as muscle mass marker was determined by creatinine kinetic modelling using pre- and post-dialysis creatinine values.
RESULTS: During the follow-up period, 89 deaths (53 from cardiovascular causes) were observed. After adjustment for age, gender, dialysis vintage, smoking, diabetes mellitus and hypertension, the highest tertile of CRP and lowest tertile of transthyretin and CI were significantly associated with all-cause mortality (relative risk (RR)=1.98 [1.12-3.47], 2.58 [1.48-4.50], 2.71 [1.42-5.19], respectively). In addition, low CI had an additive value to low levels of transthyretin. In contrast, high cholesterol (RR=0.47 [0.27-0.83], P=0.0091) and vitamin E concentrations (RR=0.46 [0.26-0.80], P= 0.006) showed a protective trend for all-cause mortality. In the multivariate analysis, transthyretin appeared as the most predictive biological marker of non-CV mortality (RR=3.78 [1.30-10.96], P=0.014), and CI of CV mortality (RR=2.61 [1.06-6.46], P=0.038), respectively. Discussion. These results confirm that uraemic malnutrition constitutes an important risk factor for mortality in HD. Beyond transthyretin, CI seems to be an additional marker routinely available and monthly determined in HD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890748     DOI: 10.1093/ndt/gfm573

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Variability of laboratory parameters is associated with frailty markers and predicts non-cardiac mortality in hemodialysis patients.

Authors:  Yuichi Nakazato; Riichi Kurane; Satoru Hirose; Akihisa Watanabe; Hiromi Shimoyama
Journal:  Clin Exp Nephrol       Date:  2015-03-19       Impact factor: 2.801

Review 2.  Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity.

Authors:  Scott E Liebman; Steven P Lamontagne; Li-Shan Huang; Susan Messing; David A Bushinsky
Journal:  Am J Kidney Dis       Date:  2011-06-12       Impact factor: 8.860

3.  Skeletal Muscle Phenotype in Patients Undergoing Long-Term Hemodialysis Awaiting Kidney Transplantation.

Authors:  Jean-Sébastien Souweine; Fares Gouzi; Éric Badia; Pascal Pomies; Valérie Garrigue; Marion Morena; Maurice Hayot; Jacques Mercier; Bronia Ayoub; Moglie Le Quintrec; Fabrice Raynaud; Jean-Paul Cristol
Journal:  Clin J Am Soc Nephrol       Date:  2021-11       Impact factor: 8.237

4.  Prealbumin as a nutrition status indicator may be associated with outcomes of geriatric hip fractures: a propensity score matching and 1-year follow-up study.

Authors:  Mingchong Liu; Shengchao Ji; Chensong Yang; Tianhao Zhang; Ning Han; Yutao Pan; Xian Xu; Jian Lin; Guixin Sun
Journal:  Aging Clin Exp Res       Date:  2022-09-21       Impact factor: 4.481

5.  The Prognostic Value of High-sensitivity C-reactive Protein and Prealbumin for Short-term Mortality in Acutely Hospitalized Multimorbid Elderly Patients: A Prospective Cohort Study.

Authors:  A Nouvenne; A Ticinesi; F Lauretani; M Maggio; G Lippi; B Prati; L Borghi; T Meschi
Journal:  J Nutr Health Aging       Date:  2016-04       Impact factor: 4.075

6.  Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients.

Authors:  Kei Fukami; Sho-Ichi Yamagishi; Kazuko Sakai; Makoto Nasu; Seiya Okuda
Journal:  Clin Kidney J       Date:  2014-07-29

7.  Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients.

Authors:  Mi Yeon Jung; Soon Young Hwang; Yu Ah Hong; Su Young Oh; Jae Hee Seo; Young Mo Lee; Sang Won Park; Jung Sun Kim; Joon Kwang Wang; Jeong Yup Kim; Ji Eun Lee; Gang Jee Ko; Heui Jung Pyo; Young Joo Kwon
Journal:  Kidney Res Clin Pract       Date:  2015-01-15

8.  Creatinine index as a surrogate of lean body mass derived from urea Kt/V, pre-dialysis serum levels and anthropometric characteristics of haemodialysis patients.

Authors:  Bernard Canaud; Alexandre Granger Vallée; Nicolas Molinari; Leila Chenine; Hélène Leray-Moragues; Annie Rodriguez; Lotfi Chalabi; Marion Morena; Jean-Paul Cristol
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

9.  Physical inactivity and protein energy wasting play independent roles in muscle weakness in maintenance haemodialysis patients.

Authors:  Jean-Sébastien Souweine; Nils Kuster; Leila Chenine; Annie Rodriguez; Laure Patrier; Marion Morena; Eric Badia; Lotfi Chalabi; Nathalie Raynal; Isabelle Ohresser; Helene Leray-Moragues; Jacques Mercier; Maurice Hayot; Moglie Le Quintrec; Fares Gouzi; Jean-Paul Cristol
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

10.  Clinical and predictive value of simplified creatinine index used as muscle mass surrogate in end-stage kidney disease haemodialysis patients-results from the international MONitoring Dialysis Outcome initiative.

Authors:  Bernard Canaud; Xiaoling Ye; Len Usvyat; Jeroen Kooman; Frank van der Sande; Jochen Raimann; Yuedong Wang; Peter Kotanko
Journal:  Nephrol Dial Transplant       Date:  2020-12-04       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.